We also assessed germline and somatic genomic imbalances in 15 patients (blood and tumor matched samples), 7 of which carried BRCA1/2 germline mutations (3 in BRCA1 and 4 in BRCA2), and 6 and 2 of which harbored BRCA1/2 wild type and BRCA1/2 UVs, respectively. The gene discussed is BRCA2; the disease is neoplasm.